Oncological impact of neoadjuvant hormonal therapy on permanent iodine-125 seed brachytherapy in patients with low- and intermediate-risk prostate cancer.

Takamoto, Atsushi; Tanimoto, Ryuta; Bekku, Kensuke; Araki, Motoo; Sadahira, Takuya; Wada, Koichiro; Ebara, Shin; Katayama, Norihisa; Yanai, Hiroyuki; Nasu, Yasutomo

Takamoto, Atsushi; Tanimoto, Ryuta; Bekku, Kensuke; Araki, Motoo; Sadahira, Takuya; Wada, Koichiro; Ebara, Shin; Katayama, Norihisa; Yanai, Hiroyuki; Nasu, Yasutomo.

Afiliação

Takamoto A; Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
Tanimoto R; Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
Bekku K; Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
Araki M; Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
Sadahira T; Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
Wada K; Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
Ebara S; Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
Katayama N; Department of Radiology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
Yanai H; Department of Pathology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
Nasu Y; Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.

Int J Urol ; 25(5): 507-512, 2018 05.

Article em En | MEDLINE | ID: mdl-29651796

Assuntos

Braquiterapia/métodos; Hormônios/uso terapêutico; Radioisótopos do Iodo/uso terapêutico; Terapia Neoadjuvante; Neoplasias da Próstata/mortalidade; Neoplasias da Próstata/terapia; Idoso; Terapia Combinada; Humanos; Japão/epidemiologia; Masculino; Pessoa de Meia-Idade; Análise Multivariada; Estadiamento de Neoplasias; Antígeno Prostático Específico/sangue; Neoplasias da Próstata/radioterapia; Dosagem Radioterapêutica; Estudos Retrospectivos; Medição de Risco; Índice de Gravidade de Doença; Análise de Sobrevida; Fatores de Tempo; Resultado do Tratamento

Palavras-chave

brachytherapy; iodine-125; neoadjuvant hormonal therapy; prostate cancer

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Braquiterapia / Terapia Neoadjuvante / Hormônios / Radioisótopos do Iodo Tipo de estudo: Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Humans / Male / Middle aged País como assunto: Asia Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google